Twinrix
TwinRix (Hepatitis B + Hepatitis A)
- November 6, 2019 Approval Letter - KINRIX
- Approval History, Letters, Reviews, and Related Documents - KINRIX
- Supporting Documents older than three years - KINRIX
November 28, 2019 - Aluminum granuloma in a child secondary to DTaP‐IPV vaccination: A case report "To our knowledge, this is the first report describing the development of an aluminum granuloma causing a persistent, pruritic nodule at the injection site following the administration of the DTaP‐IPV vaccine. We present the case of a 6‐year‐old girl who developed a severely pruritic subcutaneous nodule on her anterior right thigh at the injection site three weeks after the administration of the aluminum‐containing DTaP‐IPV (Kinrix) vaccine."
January 3, 2017 - A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine. "The adverse events were not statistically different among groups (P=0.345). Conclusions. Combined hepatitis A and B vaccine could stimulate both high level of anti-HAV and anti-HBs antibodies and not increase adverse events, providing a new choice for hepatitis B booster. The trial was registered with the ClinicalTrial.gov number NCT02445703.
January 30, 2007 - Severe necrotizing pancreatitis following combined hepatitis A and B vaccination (full text) - Necrotizing pancreatitis is a severe form of pancreatitis and is associated with substantial morbidity and mortality. We report a case of necrotizing pancreatitis that developed following combined hepatitis A and B vaccination. No other causes of pancreatitis could be determined.